title: Volumetric and angiogenic evaluation of antitumor effects with acoustic liposome and high-frequency ultrasound.
abstract: Acoustic liposomes (AL) have their inherent echogenicity and can add functionality in serving as drug carriers with tissue specificity. Nonuniform vascular structures and vascular branches/bends are evaluated by imaging the intravascular movement locus of ALs with high-frequency ultrasound (HF-US) imaging. However, the evaluation of antitumor effects on angiogenesis by ALs and HF-US imaging has not been reported. Here, we show that the combination of ALs and an HF-US imaging system is capable of noninvasively evaluating antitumor volumetric and angiogenic effects in preclinical mouse models of various cancers. In this study, the antitumor effects of cisplatin on tumor growth and angiogenesis in mice bearing two different types of tumor cells were assessed. By tracking each AL flowing in the vessel and transferring the images to personal computers, microvessel structures were mapped and reconstructed using the color difference based on SD method. The antitumor effects were confirmed with an in vivo bioluminescence imaging system and immunohistochemical analysis. Our results show that cisplatin inhibits tumor growth by decreasing intratumoral vessel area but does not affect the angiogenesis ratio in the tumor. The vascular occupancy in the outer region of the tumor was larger than that in the inner region; however, both occupancies were similar to those of the control tumor. We propose that this method of mapping microvessels with ALs and an HF-US system can serve as a new molecular imaging method for the assessment of angiogenesis and can be applied to evaluate the antitumor effects by various therapeutic agents.
authors: Graduate School of Biomedical Engineering, Tohoku University, Sendai, Miyagi, Japan. kodama@bme.tohoku.ac.jp
authors: Tetsuya
authors: T
authors: Kodama
authors: Noriko
authors: N
authors: Tomita
authors: Yoko
authors: Y
authors: Yagishita
authors: Sachiko
authors: S
authors: Horie
authors: Kenichi
authors: K
authors: Funamoto
authors: Toshiyuki
authors: T
authors: Hayase
authors: Maya
authors: M
authors: Sakamoto
authors: Shiro
authors: S
authors: Mori
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D002945:Cisplatin / Q000627:therapeutic use; D007150:Immunohistochemistry; D008081:Liposomes / Q000008:administration & dosage*; D008163:Luminescent Measurements; D051379:Mice; D008807:Mice, Inbred BALB C; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000000981:diagnostic imaging*; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000032:analysis; D014463:Ultrasonography
chemical_list: D008081:Liposomes; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D002945:Cisplatin